CTIS2023-508769-33-00
Active, not recruiting
Phase 1
Protocol with Progestin-primed Ovarian Stimulation (PPOS) in conventional treatment from the start of stimulation vs protocol with GnRH antagonists as a pituitary suppressor in patients who are going to undergo DUOSTIM with embryo accumulation for PGT-A of the embryos.
Ginefiv S.L.0 sites144 target enrollmentNovember 29, 2023
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ginefiv S.L.
- Enrollment
- 144
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Age less than 43 years . 2\.Regular menstrual cycles between 21 and 35 days. 3\.Indication for IVF with PGT\-A 4\. Both ovaries present. 5\. Ability to participate and complete the study. 6\. Give and sign consent to participate in the study.
Exclusion Criteria
- •1\.Endometriosis grade III/IV 2\.Concurrent participation in another study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Ovarian stimulation with follicle stimulating hormone (r-FSH) for women with high early follicular FSH and intra-uterine insemination (IUI) indicatioISRCTN14825568VU University Medical Centre (VUMC) (Netherlands)80
Not yet recruiting
Phase 4
Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.Stimulation in the OvaryEmbryoOocyteOocyte RetrievalFertilization in VitroBlastocystPGT-ANCT06637189Ginefiv144
Recruiting
Phase 4
The efficacy of progestin primed ovarian stimulation (PPOS) using Dienogest v.s. antagonist method during controlled ovarian stimulation(COS) for patients with endometriosisinfertilityJPRN-UMIN000044076Kamiya Ladies Clinic80
Active, not recruiting
Phase 1
Initiation of ovarian stimulation in the late follicular phaseSubfertility Oocyte donationMedDRA version: 20.0 Level: LLT Classification code 10042392 Term: Subfertility (female) System Organ Class: 100000004872MedDRA version: 20.0 Level: PT Classification code 10053370 Term: Oocyte donation System Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]EUCTR2017-005005-12-BEZ Brussel62
Completed
Not Applicable
Controlled ovarian stimulation and intrauterine insemination or in vitro-fertilisation for the first line treatment of unexplained infertilityInfertilityBest first line treatment options for unexplained infertilityPregnancy and ChildbirthISRCTN43430382Homerton University Hospital (UK)320